Serum bactericidal activity of extended-release clarithromycin against macrolide-resistant strains of Streptococcus pneumoniae

Pharmacotherapy

Volumn 22, Issue 5, 2002, Pages 593-596

  Stein, Gary E ^a   Schooley, Sharon ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NORMAL HUMAN; PHARMACODYNAMICS; PROSPECTIVE STUDY; STEADY STATE; STREPTOCOCCUS PNEUMONIAE; SUSTAINED RELEASE PREPARATION; TIME SERIES ANALYSIS;

EID: 0036236766     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.8.593.33214     Document Type: Article

References (20)

1. Pharmacokinetics and tolerability of extended-release clarithromycin
2. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae
3. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of adult patients with acute maxillary sinusitis
4. Pharmacodynamics of macrolides, azalides, and streptogramins: Effect on extracellular pathogens
5. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model
6. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
7. Comparative serum bactericidal activity of clarithromycin and azithromycin against macrolide-sensitive and -resistant strains of Streptococcus pneumoniae
8. Use of clindamycin disks to detect macrolide resistance mediated by erm B and mef E in Streptococcus pneumoniae isolates from adults and children
9. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae
10. Macrolide resistance among invasive Streptococcus pneumoniae isolates
11. Molecular characterization of penicillin-resistant Streptococcus pneumoniae isolates causing respiratory disease in the United States
12. Serum bactericidal activity as a monitor of antibiotic therapy
13. Comparison of antibiotic activities by using bactericidal activity over time
14. Effect of serum from different patient populations on the serum bactericidal test
15. Pharmacokinetic/pharmacodynamic parameters: Rationale for antimicrobial dosing of mice and men
16. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis
17. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection
18. Macrolide resistance prevalence in S. pneumoniae: Surveillance study reports vs clinical trial efficacy